Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease (Q39396170)

11 September 2017

title

Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease (English)

1 reference

Hormone Replacement Therapy

11 September 2017

main subject

1 reference

Svati H. Shah

1

1 reference

11 September 2017

Karen P. Alexander

series ordinal

2

1 reference

11 September 2017

language of work or name

1 reference

1 February 2003

1 reference

Current treatment options in cardiovascular medicine

11 September 2017

published in

1 reference

11 September 2017

volume

5

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

25-33

1 reference

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0012-1

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0012-1

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0012-1

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0012-1

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0012-1

Estrogen replacement therapy and prognosis after first myocardial infarction

21 January 2018

1 reference

12 December 2020

The protective effects of estrogen on the cardiovascular system

1 reference

12 December 2020

Hormone replacement therapy, heart disease, and other considerations

1 reference

12 December 2020

Clinical practice. Postmenopausal hormone-replacement therapy

1 reference

12 December 2020

Coronary heart disease mortality and adjuvant tamoxifen therapy

1 reference

12 December 2020

Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteries

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

12 December 2020

Decreased mortality in users of estrogen replacement therapy

1 reference

12 December 2020

Transdermal estrogen reduces vascular resistance and serum cholesterol in postmenopausal women

1 reference

12 December 2020

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

12 December 2020

Hormone replacement therapy and risk of non-fatal stroke

1 reference

12 December 2020

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

12 December 2020

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

12 December 2020

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

12 December 2020

Vasomotor and vascular effects of hormone replacement therapy

1 reference

12 December 2020

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

12 December 2020

Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Myocardial infarction and estrogen therapy in post-menopausal women

1 reference

12 December 2020

Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production

1 reference

12 December 2020

Estrogen replacement therapy after coronary angioplasty in women

1 reference

12 December 2020

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

12 December 2020

Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy

1 reference

12 December 2020

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

12 December 2020

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy

1 reference

12 December 2020

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

12 December 2020

Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up

1 reference

12 December 2020

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

12 December 2020

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

12 December 2020

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

1 reference

12 December 2020

Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women

1 reference

12 December 2020

10.1007/S11936-003-0012-1

Identifiers

DOI

1 reference

11 September 2017

1 reference